🇺🇸 Interferon Beta 1 in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Pressure Increased — 2 reports (15.38%)
  2. Injection Site Erythema — 2 reports (15.38%)
  3. Myocardial Infarction — 2 reports (15.38%)
  4. Body Temperature Increased — 1 report (7.69%)
  5. Cardiac Procedure Complication — 1 report (7.69%)
  6. Condition Aggravated — 1 report (7.69%)
  7. Coronary Artery Thrombosis — 1 report (7.69%)
  8. Covid-19 — 1 report (7.69%)
  9. Death — 1 report (7.69%)
  10. Depressed Level Of Consciousness — 1 report (7.69%)

Source database →

Other Immunology approved in United States

Frequently asked questions

Is Interferon Beta 1 approved in United States?

Interferon Beta 1 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Interferon Beta 1 in United States?

University of Turin, Italy is the originator. The local marketing authorisation holder may differ — check the official source linked above.